the Israeli Society of Gene Therapy

Lentiviruses workshop

Home Page About us President's letter The Board Bylaws Regulations Membership
Gene Therapy Course Links Contact us
Event Sponsors:

The Israeli Association for the Study of Diabetes (IASD)



Co-Event Sponsors:








Exhibit Sponsors:






What would you like to see?
Scientific program |    Posters exhibition |    Important deadline |    Local Organizing Committee (Loc) |    Scientific Committee |    Registration |    Sponsors |    Conference secretariat |    Map

Scientific program

  Lentiviruses Gene Therapy Workshop;
A Joint Israeli/UK Academic Meeting

Organized by ISGCT and ASG (The Academic Study Group)  

Monday, February 1, 2010
 Hadassah Hebrew University Hospital
Ein-Kerem, Jerusalem, Israel
Hadassah Auditorium
 

SCIENTIFIC PROGRAM

To download the program click here    

                                                

8:00 – 8:30

 

Reception – Coffee & light refreshments

SESSION I

Eithan Galun - Chairman

 

8:30 – 9:00

Adrian Thrasher


Development of lentiviral vectors for immunodeficiency
UCL Institute of Child Health, London, UK

9:00 – 9:30

Rafael J. Yanez-Munoz

Integration-deficient lentiviral vectors
Royal Holloway-University of London, London, UK

9:30 – 10:00

Simon N. Waddington

Fetal and neonatal gene transfer for disease modelling and therapy
University College London, London, UK

10:00 – 10:20

Reba Condiotti

FIV-induced tumors: distinct viral insertion sites - shared gene activation patterns
Hadassah Hebrew University Hospital, Jerusalem, Israel

10:20 – 10:35

 

C o f f e e   B r e a k

SESSION II

Adrian Thrasher - Chairman

 

10:35 – 11:05

Andrew H. Baker


Lentivirus gene transfer in vascular disease: potentials and limitations
University of Glasgow, Glasgow, UK

11:05 – 11:35

Fulvio Mavilio

Defining the onco-retroviral and lentiviral integrome in human hematopoietic cells
University of Modena and Reggio Emilia, Modena, Italy

11:35 – 12:05

Mary Collins

Lentiviral vectors as vaccines
University College London, London, UK

12:05 – 13:05

 

B r e a k – lunch is not provided!

SESSION III

Christopher Baum - Chairman

 

13:05 – 13:25

Kobi Rosenblum


Manipulation in PSD-95 expression locally in the mature cortex using shRNA and lentivirus demonstrates its necessary role in memory consolidation processes
University of Haifa, Haifa, Israel

13:25 – 13:55

Michael Themis

Non-primate lentiviral vectors and oncogenesis in a fetal mouse model  for genotoxicity
Brunel University Uxbridge, Uxbridge, UK

13:55 – 14:25

Juan A. Bueren

Advances of Gene Therapy and Cell Reprogramming for the Treatment of Fanconi Anemia
CIEMAT, Madrid, Spain

SESSION IV

Fulvio Mavilio - Chairman

 

14:25 – 14:55

Kyriacos A. Mitrophanous


ProSavin – A Gene Therapy for Parkinson’s Disease
Oxford BioMedica, Oxford, UK

14:55 – 15:10

 

C o f f e e   B r e a k

15:10 – 15:30

Amos Panet

Tropism of Lentivirus pseudotypes in solid tissues
Hebrew University, Jerusalem, Israel

15:30 – 16:00

Christopher Baum

Reducing the genotoxic potential of integrating gene vectors
Hannover Medical School, Hannover, Germany